947 related articles for article (PubMed ID: 15242981)
1. Mesenchymal stem cells and their potential as cardiac therapeutics.
Pittenger MF; Martin BJ
Circ Res; 2004 Jul; 95(1):9-20. PubMed ID: 15242981
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
Tang J; Xie Q; Pan G; Wang J; Wang M
Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
[TBL] [Abstract][Full Text] [Related]
3. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
4. Xenotransplantation of long-term-cultured swine bone marrow-derived mesenchymal stem cells.
Nakamura Y; Wang X; Xu C; Asakura A; Yoshiyama M; From AH; Zhang J
Stem Cells; 2007 Mar; 25(3):612-20. PubMed ID: 17095707
[TBL] [Abstract][Full Text] [Related]
5. Concise review: mesenchymal stromal cells: potential for cardiovascular repair.
Psaltis PJ; Zannettino AC; Worthley SG; Gronthos S
Stem Cells; 2008 Sep; 26(9):2201-10. PubMed ID: 18599808
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
7. The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction.
Nassiri SM; Khaki Z; Soleimani M; Ahmadi SH; Jahanzad I; Rabbani S; Sahebjam M; Ardalan FA; Fathollahi MS
J Biomed Sci; 2007 Nov; 14(6):745-55. PubMed ID: 17605008
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction.
Shyu KG; Wang BW; Hung HF; Chang CC; Shih DT
J Biomed Sci; 2006 Jan; 13(1):47-58. PubMed ID: 16283432
[TBL] [Abstract][Full Text] [Related]
9. Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source.
Zhang S; Ge J; Sun A; Xu D; Qian J; Lin J; Zhao Y; Hu H; Li Y; Wang K; Zou Y
J Cell Biochem; 2006 Nov; 99(4):1132-47. PubMed ID: 16795039
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats.
Hou M; Yang KM; Zhang H; Zhu WQ; Duan FJ; Wang H; Song YH; Wei YJ; Hu SS
Int J Cardiol; 2007 Feb; 115(2):220-8. PubMed ID: 16889848
[TBL] [Abstract][Full Text] [Related]
11. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts.
Qian HY; Yang YJ; Huang J; Gao RL; Dou KF; Yang GS; Li JJ; Shen R; He ZX; Lu MJ; Zhao SH
Chin Med J (Engl); 2007 Aug; 120(16):1416-25. PubMed ID: 17825171
[TBL] [Abstract][Full Text] [Related]
12. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Volloch V; Kaplan DL
Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects.
Dai W; Hale SL; Martin BJ; Kuang JQ; Dow JS; Wold LE; Kloner RA
Circulation; 2005 Jul; 112(2):214-23. PubMed ID: 15998673
[TBL] [Abstract][Full Text] [Related]
14. In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice.
Chou SH; Kuo TK; Liu M; Lee OK
J Orthop Res; 2006 Mar; 24(3):301-12. PubMed ID: 16482576
[TBL] [Abstract][Full Text] [Related]
15. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
Chen MY; Lie PC; Li ZL; Wei X
Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
[TBL] [Abstract][Full Text] [Related]
16. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A
Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
[TBL] [Abstract][Full Text] [Related]
17. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size.
Boomsma RA; Swaminathan PD; Geenen DL
Int J Cardiol; 2007 Oct; 122(1):17-28. PubMed ID: 17187879
[TBL] [Abstract][Full Text] [Related]
18. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
Poncelet AJ; Vercruysse J; Saliez A; Gianello P
Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
[TBL] [Abstract][Full Text] [Related]
19. Trafficking and differentiation of mesenchymal stem cells.
Liu ZJ; Zhuge Y; Velazquez OC
J Cell Biochem; 2009 Apr; 106(6):984-91. PubMed ID: 19229871
[TBL] [Abstract][Full Text] [Related]
20. MSC immune tolerance in cellular cardiomyoplasty.
Chiu RC
Semin Thorac Cardiovasc Surg; 2008; 20(2):115-8. PubMed ID: 18707643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
